Suppr超能文献

血清甲状腺球蛋白水平低的分化型甲状腺癌伴[¹³¹I]聚集性肺和骨转移——肿瘤随访中的一个例外?

[131I-accumulating pulmonary and bone metastases of differentiated thyroid cancer with low serum thyroglobulin levels--an exception in tumor follow-up?].

作者信息

Arning G, Ehrenheim C, Schober O, Hundeshagen H

出版信息

Nuklearmedizin. 1987 Jun;26(3):139-42.

PMID:3628022
Abstract

In the follow-up of differentiated thyroid carcinoma it is discussed whether the tumor-marker thyroglobulin can replace the 131I scan, especially when the thyroglobulin serum level is normal. A positive 131I scan of metastases in the follow-up of patients with differentiated thyroid carcinoma combined with a low serum thyroglobulin level is extremely rare. The literature shows a frequency of about 4%. Recently we found 3 cases with a positive 131I scan demonstrating pulmonary and bone metastases whereas the serum thyroglobulin level was low.

摘要

在分化型甲状腺癌的随访中,人们讨论了肿瘤标志物甲状腺球蛋白是否可以取代131I扫描,尤其是当血清甲状腺球蛋白水平正常时。在分化型甲状腺癌患者的随访中,131I扫描显示转移灶阳性而血清甲状腺球蛋白水平较低的情况极为罕见。文献显示其发生率约为4%。最近我们发现了3例131I扫描阳性的病例,显示有肺和骨转移,而血清甲状腺球蛋白水平较低。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验